Global Health · NSE: MEDANTA · BSE: 543654
Q3 FY25 results · Oct–Dec 2024
Global Health reported revenue from operations of ₹943.44 crore (up 13.3% from Q3 FY24) and net profit of ₹142.86 crore (up 15.6% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 943.44 | 832.60 | +13.3% | 956.55 | −1.4% |
| Other income | 16.02 | 21.93 | −26.9% | 18.22 | −12.0% |
| Total income | 959.46 | 854.53 | +12.3% | 974.77 | −1.6% |
| Profit before tax | 189.07 | 172.36 | +9.7% | 181.10 | +4.4% |
| Net profit for the period | 142.86 | 123.54 | +15.6% | 130.82 | +9.2% |
| Attributable to shareholders of the company | 142.91 | 123.64 | +15.6% | — | — |
| EPS, basic (₹) | 5.32 | 4.61 | +15.4% | 4.87 | +9.2% |
| Net margin (%) | 15.1 | 14.8 | 13.7 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 624.40 | 561.68 | +11.2% | 664.61 | −6.0% |
| Other income | 22.17 | 25.83 | −14.2% | 23.58 | −6.0% |
| Total income | 646.57 | 587.51 | +10.1% | 688.18 | −6.0% |
| Profit before tax | 132.31 | 120.87 | +9.5% | 143.61 | −7.9% |
| Net profit for the period | 99.31 | 87.34 | +13.7% | 104.47 | −4.9% |
| EPS, basic (₹) | 3.70 | 3.25 | +13.8% | 3.89 | −4.9% |
| Net margin (%) | 15.9 | 15.6 | 15.7 |
Consolidated
- Filed with BSE
- 04 Feb 2025, 18:12 IST
- Board meeting
- 04 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Feb 2025, 18:12 IST
- Board meeting
- 04 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE